Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Barnes-Hind was a pioneering pharmaceutical and medical device company that specialized in ophthalmology and contact lens care. Founded in 1939 by Harry Hind and Clifford Barnes, the company became a global leader in the eye care industry, particularly known for developing the first wetting solution for hard contact lenses. Throughout its history, Barnes-Hind introduced numerous innovations in contact lens technology, including the Hydrocurve soft contact lens, and therapeutic eye drops for conditions like glaucoma. The company was acquired by Revlon in 1976 and subsequently passed through several owners, including Rorer Group and Pilkington, before its assets were integrated into Wesley-Jessen and eventually CIBA Vision (Novartis). Today, the Barnes-Hind legacy remains a foundational part of modern ophthalmic care history.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Barnes-Hind.